Bridgeway Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
2019
Q1
$84K Sell
2018
Q4
$98K Hold
2018
Q3
$278K Hold
2018
Q2
$302K Buy
2018
Q1
$257K Hold
2017
Q4
$332K Sell
2017
Q3
$402K Buy